DEF: Inception Growth Seeks Another Extension Amid Delisting

Inception Growth Acquisition Limited seeks stockholder approval to extend its business combination deadline to August 13, 2026, following its delisting from Nasdaq and current trading on OTC Markets.

Summary

• A Special Meeting of Stockholders will be held on February 9, 2026, to vote on two key proposals.
• Proposal 1 is to amend the company's Charter to extend the business combination deadline from February 13, 2026, to August 13, 2026, providing an additional six months.
• Proposal 2 is to amend the Trust Agreement to allow for six one-month extensions, each requiring a deposit of $0.075 multiplied by the number of unredeemed public shares into the Trust Account.
• The company was delisted from Nasdaq on December 17, 2024, for failing to complete a business combination within 36 months of its IPO (December 8, 2024).
• Company securities now trade on OTC Markets under their prior Nasdaq trading symbols.
• As of January 16, 2026, the redemption price per Public Share was approximately $12.75, based on a Trust Account balance of approximately $2,250,589.54.
• The closing price of Public Shares on the OTC Markets on January 16, 2026, was $11.00.
• If the extension proposals are approved and fully utilized, the estimated redemption price could be approximately $13.20 per share by August 13, 2026, assuming no prior redemptions.
• If the proposals are not approved and a business combination is not completed by February 13, 2026, the company will liquidate, and warrants and rights will expire worthless.

Sentiment

Score: 2

Explanation: The company faces significant challenges, including delisting from Nasdaq, trading on less liquid OTC markets, and repeated failures to complete a business combination. While the sponsor is providing extension funding, the overall outlook is highly uncertain with substantial risks of liquidation and worthless warrants/rights.

Positives

• The Sponsor (Soul Venture Partners LLC) or its affiliates intend to contribute $0.075 per unredeemed public share as a non-interest bearing loan for each one-month extension, demonstrating continued financial support.
• Stockholders retain redemption rights, enabling them to determine whether to keep their investments for an additional period or redeem their shares for cash.

Negatives

• The company was delisted from Nasdaq on December 17, 2024, due to its failure to complete a business combination within the required 36-month timeframe.
• Securities now trade on OTC Markets, which may lead to reduced liquidity, limited market quotations, and potential classification as a 'penny stock,' imposing stricter trading rules.
• The loss of 'covered securities' status under the National Securities Markets Improvement Act of 1996 subjects the company to state-level regulation for securities offerings, making future business combinations more difficult and costly.
• Securityholders may be prohibited from trading in company securities if the company is not registered in their state, as the company currently does not plan to register in any state.
• The repeated need for extensions indicates persistent challenges in identifying and closing a suitable business combination.
• The current market price of Public Shares ($11.00 on January 16, 2026) is below the redemption price ($12.75), suggesting a lack of market confidence.
• Warrants and rights will expire worthless if the company liquidates without completing a business combination.

Risks

• **Delisting and Trading Limitations**: Securities were delisted from Nasdaq and now trade on OTC Markets, potentially leading to reduced liquidity, limited market quotations, and classification as a 'penny stock,' which imposes stricter trading rules on brokers.
• **State-Level Regulation**: Loss of 'covered securities' status means the company is subject to state securities regulations, increasing complexity and cost for future offerings and business combinations, and potentially restricting securityholders' ability to trade.
• **Failure to Complete Business Combination**: If the extension proposals are not approved or a business combination is not consummated by August 13, 2026 (if extended), the company will liquidate, and public stockholders will receive a pro-rata share of the trust account, while warrants and rights will expire worthless.
• **Foreign Investment Regulations (CFIUS)**: The sponsor is controlled by a non-U.S. person, making the company a 'foreign person' under CFIUS regulations. This could limit the pool of potential U.S. target companies, subject transactions to lengthy government review, or even prohibit a business combination, leading to liquidation.
• **Investment Company Act of 1940 (ICA)**: Prolonged holding of trust account funds in U.S. government securities or money market funds increases the risk of being deemed an unregistered investment company, which would trigger significant regulatory burdens, likely forcing liquidation and loss of investment opportunity for stockholders.
• **Liquidity Risk for Public Shares**: The company cannot assure stockholders they will be able to sell their Public Shares in the open market, even if the market price is lower than the redemption price, due to potential insufficient liquidity on the OTC Markets.

Future Outlook

The company's future outlook is contingent on stockholder approval of the proposed extensions. If approved, the company intends to extend its business combination deadline to August 13, 2026, with the sponsor providing necessary funding for these extensions. The company will continue efforts to identify and consummate an initial business combination. If the extensions are not approved or a business combination is not completed by February 13, 2026, the company will be required to liquidate, resulting in public stockholders receiving a pro-rata share of the trust account and warrants/rights expiring worthless. Securities are expected to continue trading on the OTC Markets.

Management Comments

• "We believe that such redemption right enables its holders of Public Shares to determine whether to keep their investments for an additional period of time if the Company does not complete a business combination on or before the Current Termination Date."
• "After consultation with Soul Venture Partners LLC (the Sponsor), the Company’s management team has reasons to believe that, if the Charter Amendment and the Trust Amendment proposals are approved, the Sponsor or its affiliates or designees will, in connection with each one-month extension, contribute an aggregate amount equal to $0.075 multiplied by the number of Public Shares issued in the IPO (each, a Public Share) that has not been redeemed by the public stockholders, to the Company as a loan... for the Company to deposit the funds into the Trust Account as the Extension Payment prior to the applicable deadlines."

Industry Context

This filing highlights the increasing challenges faced by Special Purpose Acquisition Companies (SPACs) in the current market, particularly those struggling to identify and complete suitable business combinations within initial timelines. The delisting from Nasdaq and subsequent trading on OTC Markets is a significant negative trend for SPACs that fail to execute. The repeated extensions and the need for sponsor funding for these extensions are indicative of a 'distressed' SPAC scenario, where the initial investment thesis has not materialized. The mention of CFIUS and Investment Company Act risks also reflects heightened regulatory scrutiny and operational complexities for SPACs, especially those with foreign sponsors, further narrowing the pool of potential targets.

Comparison to Industry Standards

• The company's delisting from Nasdaq for failing to complete a business combination within 36 months (December 8, 2024) is a significant underperformance compared to successful SPACs that typically complete mergers within their initial 15-24 month or first extended timelines.
• Trading on OTC Markets rather than a major exchange like Nasdaq or NYSE places the company in a less liquid and less transparent trading environment, contrasting sharply with the typical SPAC lifecycle aiming for a major exchange listing post-merger.
• The repeated need for extensions, now seeking a sixth extension period, is far beyond the typical operational lifespan for SPACs, indicating severe difficulties in identifying or closing a target acquisition.
• The current market price of $11.00 being below the redemption price of $12.75 suggests a lack of market confidence in the company's ability to find an attractive business combination, unlike successful SPACs where the market price often trades at or above the trust value in anticipation of a strong deal.
• The explicit mention of CFIUS and Investment Company Act risks highlights specific regulatory hurdles that many SPACs, particularly those with foreign affiliations, must navigate, which can be more complex and time-consuming than for domestic-focused SPACs, further limiting their competitive position.

Corporate Governance

Related Party Transactions

• The Sponsor (Soul Venture Partners LLC) or its affiliates intend to contribute an aggregate amount equal to $0.075 multiplied by the number of unredeemed Public Shares as a non-interest bearing loan for each one-month extension.
• These loans are repayable by the company to the Sponsor upon consummation of an initial business combination and will be forgiven by the Sponsor or its affiliate if the company is unable to consummate an initial business combination (except to the extent of any funds held outside of the Trust Account).

Stakeholder Impact

• **Shareholders**: Face continued uncertainty regarding a business combination, potential for further dilution if more shares are redeemed, and the risk of warrants/rights expiring worthless. Those who redeem will receive cash at a price potentially higher than the current market price. Those who hold will have their investment tied up longer with the hope of a future business combination. Trading liquidity is reduced due to OTC listing.
• **Creditors**: In the event of liquidation, the company's obligations under Delaware law to provide for claims of creditors will be met from lawfully available funds.
• **Management/Sponsor**: The sponsor is committing additional capital (loans) to extend the company's life, indicating a continued effort to find a business combination, but also bears the risk of these loans being forgiven if no deal is closed.

Next Steps

• Hold a Special Meeting of Stockholders on February 9, 2026, to vote on the Charter Amendment and Trust Amendment proposals.
• If approved, the company will make monthly deposits into the Trust Account to extend the business combination deadline up to August 13, 2026.
• Continue efforts to identify and consummate an initial business combination.
• If proposals are not approved or a business combination is not completed by February 13, 2026, the company will liquidate.

Key Dates

Recommendation

The company has been delisted from Nasdaq, trades on the less liquid OTC Markets, and has repeatedly failed to secure a business combination, necessitating multiple extensions. The market price is already below the redemption value, indicating a lack of confidence. Significant risks, including potential liquidation, worthless warrants/rights, and regulatory hurdles (CFIUS, ICA), make this a high-risk investment. While the sponsor is providing extension funding, the fundamental issues remain. Investors should consider redeeming their shares if the redemption price remains above the market price, or selling on the open market if liquidity allows, to avoid further capital erosion and opportunity cost.

Keywords

SPAC, Inception Growth Acquisition Limited, Business Combination Extension, Nasdaq Delisting, OTC Markets, Trust Account, Redemption Rights, CFIUS, Investment Company Act, Corporate Governance, Shareholder Meeting, Special Purpose Acquisition Company, Proxy Statement